Artarmon, Australia

Daniel John Parker

This inventor holds 8 USPTO granted patents and 20 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Saluda Medical Pty Limited. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel John Parker. Retrieved from https://idiyas.com/inventor/daniel-john-parker-7k2l0rq6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 2.7

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Daniel John Parker

Introduction

Daniel John Parker is a notable inventor based in Artarmon, Australia. He has made significant strides in the field of neurostimulation therapy, particularly in adapting these therapies to accommodate age-related physiological changes. His work is crucial in enhancing the effectiveness of medical devices designed for neurostimulation.

Latest Patents

Daniel holds a patent for the "Adaptation of neurostimulation therapy to age-related physiological changes." This patent discloses a method for adapting the operation of an implantable device that delivers neurostimulation therapy to patients. The method involves delivering therapy to electrically excitable tissue, measuring a physiological characteristic of the patient, adjusting therapy parameters based on a schedule of adjustment and the measured characteristics, and repeating the process to ensure optimal treatment.

Career Highlights

Daniel is currently associated with Saluda Medical Pty Limited, where he applies his expertise in neurostimulation technology. His innovative approach has the potential to significantly improve patient outcomes by personalizing therapy based on individual physiological changes.

Collaborations

Daniel has collaborated with notable colleagues, including John Louis Parker and Peter Scott Vallack. Their combined efforts contribute to advancing the field of neurostimulation and enhancing the effectiveness of medical devices.

Conclusion

Daniel John Parker's contributions to neurostimulation therapy exemplify the impact of innovation in medical technology. His work not only addresses the challenges posed by age-related physiological changes but also paves the way for future advancements in patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…